Filing Details

Accession Number:
0001127602-22-008445
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-07 17:08:23
Reporting Period:
2022-03-03
Accepted Time:
2022-03-07 17:08:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1287981 Jed John Kennedy C/O Conmed Corporation
11311 Concept Boulevard
Largo FL 33773
Group Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-03 5,092 $59.96 14,947 No 4 M Direct
Common Stock Disposition 2022-03-03 5,092 $144.25 9,855 No 4 S Direct
Common Stock Acquisiton 2022-03-03 1,790 $78.76 11,645 No 4 M Direct
Common Stock Disposition 2022-03-03 1,790 $144.32 9,855 No 4 S Direct
Common Stock Acquisiton 2022-03-03 832 $97.69 10,687 No 4 M Direct
Common Stock Disposition 2022-03-03 832 $144.33 9,855 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2022-03-03 5,092 $0.00 5,092 $59.96
Common Stock Options To Purchase Common Stock Disposition 2022-03-03 1,790 $0.00 1,790 $78.76
Common Stock Options To Purchase Common Stock Disposition 2022-03-03 832 $0.00 832 $97.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,400 2028-03-01 No 4 M Direct
3,800 2029-03-01 No 4 M Direct
6,768 2030-03-02 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.25 to $144.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.50. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.40. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  4. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
  5. The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period